Table IV.
LTβR, p-p65 and p52 protein expression in the healthy bladder mucosa, chronic cystitis and BCa groups.
| LTβR | p-p65 | p52 | ||||
|---|---|---|---|---|---|---|
|
|
|
|
||||
| Group (N) | Positive rate (%) | MD ×10 (mean ± SD) | Positive rate (%) | MD ×10 (mean ± SD) | Positive rate (%) | MD ×10 (mean ± SD) |
| Healthy bladder mucosa (15) | 13.3 | 2.7±0.8 | 6.7 | 1.7±0.7 | 6.7 | 1.9±0.9 |
| Chronic cystitis (30) | 90.0 | 9.0±2.2a | 83.3 | 5.8±1.5a | 93.3 | 6.6±1.7a |
| BCa (73) | 69.8 | 5.9±2.3a,b | 56.2 | 3.5±1.6a,b | 63.0 | 4.0±2.0a,b |
a
P<0.05 compared to the healthy bladder mucosa group;
b
P<0.05 compared to the healthy bladder mucosa and chronic cystitis group.
LTβR, lymphotoxin β receptor; p-p65, phosphorylated p65; BCa, bladder cancer; MD, mean density; SD, standard deviation.